<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9442374" created="29/03/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9442374</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Control of <term id="T1" lex="NF-kappa_B_activity" sem="Other"><term id="T2" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activity</term> by the <term id="T3" lex="I_kappa_B_beta_inhibitor" sem="Protein_molecule">I kappa B beta inhibitor</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Regulation"/>
<theme idref="T1"/>
<cause idref="T3"/>
<clue><clueType>Control</clueType> <linkTheme>of</linkTheme> NF-kappa B activity <linkCause>by</linkCause> the I kappa B beta inhibitor.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T4" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> <term id="T5" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> is maintained in an <term id="T6" lex="inactive_cytoplasmic_state" sem="Other">inactive cytoplasmic state</term> by <term id="T7" lex="I_kappa_B_inhibitor" sem="Protein_family_or_group">I kappa B inhibitors</term>.</sentence>
<event KT="Fact" id="E2">
<type class="Negative_regulation"/>
<theme idref="T5"/>
<cause idref="T7"/>
<clue>The transcription factor NF-kappa B is <clueType>maintained</clueType> in an <clueType>inactive</clueType> <clueLoc>cytoplasmic</clueLoc> state <linkCause>by</linkCause> I kappa B inhibitors.</clue>
</event>
<sentence id="S3">In <term id="T8" lex="mammalian_cell" sem="Cell_natural">mammalian cells</term>, <term id="T9" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> and <term id="T10" lex="I_kappa_B_beta_protein" sem="Protein_molecule"><term id="T11" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term> proteins</term> have been purified and shown to be the inhibitors of <term id="T12" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> through their association with the <cons id="T13" lex="(OR p65_subunit c-Rel_subunit)" sem="(OR Protein_molecule Protein_molecule)"><frag id="F1"><term id="A1" sem="Protein_molecule">p65</term></frag> or <frag id="F2"><term id="A2" sem="Protein_molecule">c-Rel</term></frag> <frag id="F3"><term id="A3" sem="Protein_molecule">subunits</term></frag></cons>.</sentence>
<event KT="Analysis" Source="Other" id="E5">
<type class="Negative_regulation"/>
<theme idref="T12"/>
<cause idref="E9"/>
<clue><clueLoc>In mammalian cells</clueLoc>, I kappa B alpha and I kappa B beta proteins <clueSource>have been</clueSource> purified and <clueKT>shown</clueKT> to be the <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> NF-kappa B <linkCause>through</linkCause> their association with the p65 or c-Rel subunits.</clue>
</event>
<event KT="Analysis" Source="Other" id="E6">
<type class="Negative_regulation"/>
<theme idref="T12"/>
<cause idref="E10"/>
<clue>In mammalian cells, I kappa B alpha and I kappa B beta proteins <clueSource>have been</clueSource> purified and <clueKT>shown</clueKT> to be the <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> NF-kappa B <linkCause>through</linkCause> their association with the p65 or c-Rel subunits.</clue>
</event>
<event KT="Analysis" Source="Other" id="E7">
<type class="Negative_regulation"/>
<theme idref="T12"/>
<cause idref="E11"/>
<clue>In mammalian cells, I kappa B alpha and I kappa B beta proteins <clueSource>have been</clueSource> purified and <clueKT>shown</clueKT> to be the <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> NF-kappa B <linkCause>through</linkCause> their association with the p65 or c-Rel subunits.</clue>
</event>
<event KT="Analysis" Source="Other" id="E8">
<type class="Negative_regulation"/>
<theme idref="T12"/>
<cause idref="E12"/>
<clue>In mammalian cells, I kappa B alpha and I kappa B beta proteins <clueSource>have been</clueSource> purified and <clueKT>shown</clueKT> to be the <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> NF-kappa B <linkCause>through</linkCause> their association with the p65 or c-Rel subunits.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Binding"/>
<theme idref="T9"/>
<theme idref="A1" idref1="A3"/>
<clue>In mammalian cells, I kappa B alpha and I kappa B beta proteins have been purified and shown to be the inhibitors of NF-kappa B through their <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> the p65 or c-Rel subunits.</clue>
</event>
<event KT="Analysis" id="E10">
<type class="Binding"/>
<theme idref="T9"/>
<theme idref="A2" idref1="A3"/>
<clue>In mammalian cells, I kappa B alpha and I kappa B beta proteins have been purified and shown to be the inhibitors of NF-kappa B through their <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> the p65 or c-Rel subunits.</clue>
</event>
<event KT="Analysis" id="E11">
<type class="Binding"/>
<theme idref="T11"/>
<theme idref="A1" idref1="A3"/>
<clue>In mammalian cells, I kappa B alpha and I kappa B beta proteins have been purified and shown to be the inhibitors of NF-kappa B through their <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> the p65 or c-Rel subunits.</clue>
</event>
<event KT="Analysis" id="E12">
<type class="Binding"/>
<theme idref="T11"/>
<theme idref="A2" idref1="A3"/>
<clue>In mammalian cells, I kappa B alpha and I kappa B beta proteins have been purified and shown to be the inhibitors of NF-kappa B through their <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> the p65 or c-Rel subunits.</clue>
</event>
<sentence id="S4">In addition, we have isolated a third <term id="T14" lex="NF-kappa_B_inhibitor" sem="Protein_family_or_group"><term id="T15" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> inhibitor</term>, <term id="T16" lex="I_kappa_B_epsilon" sem="Protein_molecule">I kappa B epsilon</term> (1).</sentence>
<sentence id="S5">Upon treatment with a large variety of <term id="A4" sem="Organic_compound_other">inducers</term>, <term id="T17" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>, <term id="T18" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term> are proteolytically degraded, resulting in <term id="T19" lex="NF-kappa_B_translocation" sem="Other"><term id="T20" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> translocation</term> into the <term id="T21" lex="nucleus" sem="Cell_component">nucleus</term>.</sentence>
<event id="E14">
<type class="Protein_catabolism"/>
<theme idref="T17"/>
<clue><clueExperiment>Upon treatment with a large variety of inducers</clueExperiment>, I kappa B alpha, I kappa B beta are <clueType>proteolytically degraded</clueType>, resulting in NF-kappa B translocation into the nucleus.</clue>
</event>
<event id="E15">
<type class="Protein_catabolism"/>
<theme idref="T18"/>
<clue><clueExperiment>Upon treatment with a large variety of inducers</clueExperiment>, I kappa B alpha, I kappa B beta are <clueType>proteolytically degraded</clueType>, resulting in NF-kappa B translocation into the nucleus.</clue>
</event>
<event id="E16">
<type class="Localization"/>
<theme idref="T20"/>
<clue>Upon treatment with a large variety of inducers, I kappa B alpha, I kappa B beta are proteolytically degraded, resulting in NF-kappa B <clueType>translocation</clueType> <clueLoc>into the nucleus</clueLoc>.</clue>
</event>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="E14"/>
<clue>Upon treatment with a large variety of inducers, I kappa B alpha, I kappa B beta are proteolytically degraded, <clueType>resulting</clueType> <linkTheme>in</linkTheme> NF-kappa B translocation into the nucleus.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="E15"/>
<clue>Upon treatment with a large variety of inducers, I kappa B alpha, I kappa B beta are proteolytically degraded, <clueType>resulting</clueType> <linkTheme>in</linkTheme> NF-kappa B translocation into the nucleus.</clue>
</event>
<sentence id="S6">Here we show that in <term id="T22" lex="E29.1_T_cell_hybridoma" sem="Cell_cultured">E29.1 T cell hybridoma</term> <term id="T23" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> and <term id="T24" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term> are equally associated with <term id="T25" lex="p65" sem="Protein_molecule">p65</term> and that <term id="T26" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term> is degraded in response to <term id="T27" lex="TNF_alpha" sem="Protein_molecule">TNF alpha</term> in contrast to what has been originally published.</sentence>
<event KT="Analysis" id="E19">
<type class="Binding"/>
<theme idref="T23"/>
<theme idref="T25"/>
<clue>Here we <clueKT>show</clueKT> that <clueLoc>in E29.1 T cell hybridoma</clueLoc> I kappa B alpha and I kappa B beta are equally <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> p65 and that I kappa B beta is degraded in response to TNF alpha in contrast to what has been originally published.</clue>
</event>
<event KT="Analysis" id="E20">
<type class="Binding"/>
<theme idref="T24"/>
<theme idref="T25"/>
<clue>Here we <clueKT>show</clueKT> that <clueLoc>in E29.1 T cell hybridoma</clueLoc> I kappa B alpha and I kappa B beta are equally <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> p65 and that I kappa B beta is degraded in response to TNF alpha in contrast to what has been originally published.</clue>
</event>
<event KT="Other" id="E21">
<type class="Protein_catabolism"/>
<theme idref="T26"/>
<clue>Here we show that in E29.1 T cell hybridoma I kappa B alpha and I kappa B beta are equally associated with p65 and that I kappa B beta is <clueType>degraded</clueType> in response to TNF alpha in contrast to what has been originally published.</clue>
</event>
<event KT="Analysis" id="E3">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="T27"/>
<clue>Here we <clueKT>show</clueKT> that in E29.1 T cell hybridoma I kappa B alpha and I kappa B beta are equally associated with p65 and that I kappa B beta is degraded <linkCause>in response to</linkCause> TNF alpha in contrast to what has been originally published.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S7">Our data also suggest that, unlike <term id="T28" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term>, <term id="T29" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term> is constitutively phosphorylated and resynthesized as a <term id="T30" lex="hypophosphorylated_form" sem="Protein_family_or_group">hypophosphorylated form</term>.</sentence>
<event CL="L2" KT="Analysis" id="E22" uncertainty="probable">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T29"/>
<clue>Our data also <clueKT><clueCL>suggest</clueCL></clueKT> that, unlike I kappa B alpha, I kappa B beta is constitutively <clueType>phosphorylated</clueType> and resynthesized as a hypophosphorylated form.</clue>
</event>
<event CL="L2" KT="Analysis" id="E23" uncertainty="probable">
<type class="Protein_modification"/>
<theme idref="T29" idref1="T30"/>
<clue>Our data also <clueKT><clueCL>suggest</clueCL></clueKT> that, unlike I kappa B alpha, I kappa B beta is constitutively phosphorylated and <clueType>resynthesized</clueType> as a hypophosphorylated form.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E24" uncertainty="probable">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T28"/>
<clue>Our data also <clueKT><clueCL>suggest</clueCL></clueKT> that, <clueType><cluePolarity>unlike</cluePolarity></clueType> I kappa B alpha, I kappa B beta is constitutively <clueType>phosphorylated</clueType> and resynthesized as a hypophosphorylated form.</clue>
<comment>CAUTION: SEE</comment></event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E25" uncertainty="probable">
<type class="Protein_modification"/>
<theme idref="T28" idref1="T30"/>
<clue>Our data also <clueKT><clueCL>suggest</clueCL></clueKT> that, <clueType><cluePolarity>unlike</cluePolarity></clueType> I kappa B alpha, I kappa B beta is constitutively phosphorylated and <clueType>resynthesized</clueType> as a hypophosphorylated form.</clue>
<comment>CAUTION: SEE</comment></event>
<sentence id="S8">The absence of <term id="A5" sem="Protein_molecule">slow migrating forms of <term id="T31" lex="I_kappa_B_beta" sem="Protein_molecule">I kappa B beta</term></term> following stimulation suggests that the <term id="T32" lex="phosphorylation" sem="Other">phosphorylation</term> does not necessarily constitute the <term id="T33" lex="signal-induced_event" sem="Other">signal-induced event</term> which targets the molecule for <term id="T34" lex="proteolysis" sem="Other">proteolysis</term>.</sentence>
<event KT="Other" id="E26">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<clue>The absence of slow migrating forms of I kappa B beta following <clueType>stimulation</clueType> suggests that the phosphorylation does not necessarily constitute the signal-induced event which targets the molecule for proteolysis.</clue>
</event>
<event KT="Other" id="E27">
<type class="Negative_regulation"/>
<theme idref="A5"/>
<cause idref="E26"/>
<clue>The <clueType>absence</clueType> <linkTheme>of</linkTheme> slow migrating forms of I kappa B beta <linkCause>following</linkCause> stimulation suggests that the phosphorylation does not necessarily constitute the signal-induced event which targets the molecule for proteolysis.</clue>
<comment>TPS: A5</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
